Observations indicate a marked reduction in urine protein levels, UACR, urinary albumin excretion rate (UAER), and urinary MCP-1/creatinine (uMCP-1/Cr) levels in patients with early DN (Yan et al., 2018). This evidence concerns the gene CCL2 and liver dysplastic nodule.